Transcend Capital Advisors, LLC Novo Nordisk A S Transaction History
Transcend Capital Advisors, LLC
- $1.44 Billion
- Q3 2024
A detailed history of Transcend Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 4,519 shares of NVO stock, worth $483,804. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,519
Previous 3,198
41.31%
Holding current value
$483,804
Previous $456,000
17.98%
% of portfolio
0.04%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding NVO
# of Institutions
1,955Shares Held
319MCall Options Held
5.32MPut Options Held
5.04M-
Jennison Associates LLC20.2MShares$2.16 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.56 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.52 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.42 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.34 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $242B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...